Informed-money record

NAUT · Nautilus Biotechnology, Inc.

Disclosed informed-money activity on this name over the last 12 months — corporate insiders, institutions, and members of Congress, from public-domain SEC and congressional filings. A dated factual record with receipts; interpretation is yours.

Bullish filings

Bearish filings

Named actors

Disclosed $ (bull / bear)

$71K / $70.5M + 1 of unknown size

Recent disclosures

15 of 15 in the window · linked to source

Date	Who	What	Disclosed $	Receipt
2026-09-18	Issuer (share issuance)	priced an offering	—	SEC ↗
2026-06-02	10% owner / other Andreessen Marc L	sold	$10.8M	SEC ↗
2026-06-02	10% owner / other AH Bio Fund II, L.P.	sold	$902K	SEC ↗
2026-06-02	10% owner / other AH Bio Fund II, L.P.	sold	$10.8M	SEC ↗
2026-06-02	10% owner / other AH Equity Partners Bio II, L.L.C.	sold	$902K	SEC ↗

Want the read, not just the record?

Members see how notable each move is, the actor's past track record, cross-source convergence, and alerts on this name.

Start free — 1 week, no card →

Dispute or correct this record

Events dated by when the activity occurred (a trade's transaction date; a notice, stake, or announcement at its filing date); the linked filing is the authoritative record. Directional public-domain disclosures only. Descriptive, not investment advice. Methodology · Today's notable signals